Mayer U, Pöschl E, Nischt R, Specks U, Pan T C, Chu M L, Timpl R
Max-Planck-Institut für Biochemie, Martinsried, Germany.
Eur J Biochem. 1994 Oct 15;225(2):573-80. doi: 10.1111/j.1432-1033.1994.00573.x.
The Kunitz-type inhibitor motif (domain C5) present at the C-terminus of the human collagen alpha 3(VI) chain was prepared in a recombinant form from the culture medium of stably transfected kidney cell clones. The 76-residue protein was disulfide bonded and showed a high stability against protease treatment. The recombinant protein lacked, however, any inhibitory activity for trypsin, thrombin, kallikrein and several other proteases, which could be due to a few unusual substitutions in the region crucial for inhibitor binding. A sensitive radioimmunoassay detected low concentrations of C5 epitopes in normal human serum and fibroblast culture medium and showed a lack of cross-reaction with aprotinin. Antibodies against C5 immunoprecipitated collagen VI obtained from fibroblast medium. The C5 epitopes could not be detected on intact collagen VI purified from guanidine extracts of human placenta. Collagen VI was shown to possess several alpha 3(VI) chain bands (approximately 200 kDa) and reacted strongly with antibodies to an N-terminal recombinant fragment. Immunofluorescence with anti-C5 antibodies failed to stain several human tissues but produced a distinct intracellular staining of cultured fibroblasts. The data indicate the rapid loss of the C5 domain after biosynthesis of collagen VI.
人胶原蛋白α3(VI)链C末端存在的Kunitz型抑制剂基序(结构域C5)以重组形式从稳定转染的肾细胞克隆的培养基中制备。这种76个残基的蛋白质通过二硫键连接,并且对蛋白酶处理表现出高度稳定性。然而,重组蛋白对胰蛋白酶、凝血酶、激肽释放酶和其他几种蛋白酶没有任何抑制活性,这可能是由于在抑制剂结合关键区域存在一些不寻常的取代。一种灵敏的放射免疫测定法检测到正常人血清和成纤维细胞培养基中低浓度的C5表位,并且显示与抑肽酶无交叉反应。抗C5抗体免疫沉淀从成纤维细胞培养基中获得的胶原蛋白VI。在从人胎盘胍提取物中纯化的完整胶原蛋白VI上未检测到C5表位。胶原蛋白VI显示具有几条α3(VI)链带(约200 kDa),并且与针对N末端重组片段的抗体强烈反应。用抗C5抗体进行免疫荧光未能对几种人体组织染色,但对培养的成纤维细胞产生明显的细胞内染色。数据表明胶原蛋白VI生物合成后C5结构域迅速丢失。